• Estudo De Custos Da Leishmaniose Visceral No Brasil

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women

    Oct 1, 2017, 00:00

  • Impacto De Una Ley De Bioequivalencia En El Precio De Medicamentos

    Oct 1, 2017, 00:00

  • Burden of High Disease Activity in Systemic Lupus Erythematosus (SLE)- Results of A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Adequacy of Glycemic Control in Greek Patients with Type 2 Diabetes Mellitus Treated with Metformin Monotherapy at the Maximum Tolerated Dose- The Reload Study

    Oct 1, 2017, 00:00

  • Influenza Vaccination Among Pregnant Women- Exploratory Analysis From The 2012-2015 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Long-Term Benefits of LDL Cholesterol Lowering In Young Adulthood- A Computer Simulation Study

    Oct 1, 2017, 00:00

  • Insertable Cardiac Monitor Versus Standard of Care For Detection Of Atrial Fibrillation In Patients Following Cryptogenic Stroke- A Dutch Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of Multivalent Vaccination Against Infectious Causes of Reproductive Disorders in Brazilian Cow-Calf Beef Herds Using Artificial Insemination

    Oct 1, 2017, 00:00

  • Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of IVF Treatments Gonal-F® Versus HP-HMG in the United Arab Emirates (UAE)

    Oct 1, 2017, 00:00

  • A Comparative Analysis Of The Health Care Utilization And Costs Of Patients Diagnosed With And Without Liver Cancer In The US Medicare Population

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from A Brazilian Perspective

    Oct 1, 2017, 00:00

  • Analysis of Clinical And Economic Effectiveness of Statins For Secondary Prevention of Cardiovascular Disease In Kazakhstan

    Oct 1, 2017, 00:00

  • Leveraging Electronic Health Records to Meet The Real World Evidence Needs of Hta- A Uk Perspective

    Oct 1, 2017, 00:00

  • The Impact of Trial Design on Network Meta-Analysis and Decision-Making- A Working Example in Ulcerative Colitis

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Pharmacotherapy Costs Study For Patients With Rare Endocrine Diseases In Bulgaria – A Pilot Study

    Oct 1, 2017, 00:00

  • Productivity Costs Related to Bortezomib And Carfilzomib Administration For Multiple Myeloma In Finland

    Oct 1, 2017, 00:00

  • Uses and Applications of Eq-5d in Latin America the Caribbean- Systematic Review and Bibliometric Analysis

    Oct 1, 2017, 00:00

  • A Comparison of Health Technology Assessment (HTA) Requirements For Systematic Literature Reviews (SLRS)

    Oct 1, 2017, 00:00

  • Evaluating Access To Treatment- A Comparison of The Expected Number of Patients with Metastatic Colorectal Cancer (Mcrc) To Those Effectively Treated in The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • The Use of The Propensity Score In The Cost-Effectiveness Analysis of The Atrial Fibrillation Treatment

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Arterial Hypertension In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • A Minimally Invasive Hemodynamic Monitoring Device for the Brazilian Health System- Is Flotrac® Cost-Effective?

    Oct 1, 2017, 00:00

  • Risk Factors of Asthma and Their Role in Triggering The Asthmatic Attack

    Oct 1, 2017, 00:00

  • Obstructive Sleep Apnea Treatment Guidelines - Implementation Status In Oecd-Countries

    Oct 1, 2017, 00:00

  • Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents In Chronic Hepatitis C Infection- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Exploring Factors Explaining Treatment Acceptance in Patients Suffering from a Chronic Disease

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Of Novel Treatments For Advanced Melanoma- A Systematic Literature Review And Network Meta-Analysis Of Effectiveness And Safety Outcomes

    Oct 1, 2017, 00:00

  • Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes- Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure

    Oct 1, 2017, 00:00

  • Pro Instruments used in Studies of Pulmonary Hypertension Since 1960

    Oct 1, 2017, 00:00

  • A Systematic Review To Evaluate The Association Between Medication Adherence And Personality Traits

    Oct 1, 2017, 00:00

  • A Population-Based Study on Clinical Outcomes and Medical Costs of Laparoscopic Versus Open Surgery for Colon Cancer Patients in Taiwan

    Oct 1, 2017, 00:00

  • Comparison Of Costs Between Hospital And Home Infusions In Patients Treated With Laronidase

    Oct 1, 2017, 00:00

  • Reduced Needlestick Injuries And HBV Infections In Chinese Healthcare Workers From Blunt-Tip Suture Needles In Cesarean Sections- A Markov Simulation

    Oct 1, 2017, 00:00

  • Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression

    Oct 1, 2017, 00:00

  • Comparisons Of Healthcare Utilization And Cost Impact Of Managing Type 2 Diabetes Across The System Of Care In Medicare Beneficiaries

    Oct 1, 2017, 00:00

  • Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia- Development of Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Unmet Pharmaceutical Needs During The Economic Crisis In Greece

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System

    Oct 1, 2017, 00:00

  • Integrated Care System For Hypertension In China- What The Cost Will Be For Government? A budget impact analysis

    Oct 1, 2017, 00:00

  • Positive Externalities of austerity? The Case of Smoking Cessation During the Financial Crisis in Greece

    Oct 1, 2017, 00:00

  • Extrapolation of Adult Data for Pediatric Drug Benefit Assessment In The Amnog Dossier In The Light of The New Amvsg

    Oct 1, 2017, 00:00

  • Economic and Clinical Impact of Serum-Derived Bovine Immunoglobulin / Protein Isolate (SBI) in the Management of Chronic Diarrhea in Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • Estimation of The Cost of Metastatic Melanoma in France Using Melbase Data

    Oct 1, 2017, 00:00

  • Real World Data on Multiple Myeloma Treatment Patterns- First and Second-Line Treatment in the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Assessing the Economic and Humanistic Burden of Psoriatic Arthritis in Brazil

    Oct 1, 2017, 00:00

  • Risk Factors Associated With Tuberculosis In Punjab, Pakistan

    Oct 1, 2017, 00:00

  • The Economic Impact Of Providing Dengue Vaccination In The Workplace In Brazil

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis Of Seasonal Quadrivalent Influenza Vaccine In Italy Using A Static Model

    Oct 1, 2017, 00:00

  • The Choice of Effectiveness Criteria Affects Conclusions of Economic Evaluation of Health Care Innovations- Example Based on A Randomised Multicenter Trial Comparing Two Reduced Intensity Conditioning Regimen (FLU-BU-ATG) Vs. (FLU-TBI) For ...

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cobicistat-Boosted Darunavir In Hiv-Infected Patients In Mexico

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Comparison of Glasdegib Plus Low Dose ARA-C Versus A Hypomethylating Agent For Acute Myeloid Leukemia Patients Ineligible For Intensive Chemotherapy

    Oct 1, 2017, 00:00

  • Oral Estrogen Therapy Is Associated With Reduced Risk of Hepatitis B Virus–Related Hepatoma In Taiwanese Postmenopausal Women

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Pembrolizumab for The First-Line Treatment of Metastatic Non-Small Cell Lung Carcinoma in Portugal

    Oct 1, 2017, 00:00

  • Orphan Drugs In The Uk, Do They Meet The Nice Highly Specialised Technology Threshold?

    Oct 1, 2017, 00:00

  • Healthcare Costs Associated with Cervical Cancer, Precancerous Lesions, and Genital Warts Treatment in Taiwan

    Oct 1, 2017, 00:00

  • Analysis Of The Behavior Of The Expenditure Curve In Oncology And Other Causes Of Death In The Last 5 Years Of Life – Brazil Real-World Health Care Data

    Oct 1, 2017, 00:00

  • Improving Disease Detection Through Methods To Reduce Patient Heterogeneity

    Oct 1, 2017, 00:00

  • Cambio En La Carga De Enfermedad Ajustada Por Riesgo Para Una Población Afiliada A UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have “Full-Health” by EQ-5D-5L

    Oct 1, 2017, 00:00

  • Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil

    Oct 1, 2017, 00:00

  • Eating Habits and Physical Exercise Practices of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Development of a Screening Questionnaire to Detect Heavy Menstrual Bleeding in Women of Child-Bearing Age

    Oct 1, 2017, 00:00

  • Increased Episode Rate of Medically-Attended Acute Gastroenteritis In Diabetics In England

    Oct 1, 2017, 00:00

  • The Cystic Fibrosis Impact Questionnaire (CF-IQ)- Qualitative Development And Cognitive Evaluation Of A New Patient-Reported Outcome Instrument To Assess The Life Impacts Of Cystic Fibrosis

    Oct 1, 2017, 00:00

  • The Clinical and Cost-Effectiveness of Different Maternal Syphilis Screening Strategies in Brazil

    Oct 1, 2017, 00:00

  • Pro Instruments Used in Studies of Skin Cancer Since 1960

    Oct 1, 2017, 00:00

  • The Examination Of Location And Frequency Of Pain In Weight Training

    Oct 1, 2017, 00:00

  • Analysis Of Epidemiological Data On Burden Disease In Europe

    Oct 1, 2017, 00:00

  • Development Of A Descriptive System For Measuring Patient Experience

    Oct 1, 2017, 00:00

  • Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Servi 24-Month Results of a Prospective Cohort Study

    Oct 1, 2017, 00:00

  • A Systematic Review Of Calibration In Population Models

    Oct 1, 2017, 00:00

  • Reporting Of The Use Of Research And Publication Guidelines In Health Economic And Outcomes Research Publications In Inflammatory Bowel Disease – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • The Impact of Beliefs Towards Illness and Medications on Adherence and Clinical Outcomes in Acute Coronary Syndrome Patients in Hong Kong

    Oct 1, 2017, 00:00

  • Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico

    Oct 1, 2017, 00:00

  • Retrospective Analysis of the Use of Incremental Cost-Effectiveness Ratio (Icer) in Technology Incorporation in the Brazilian Public Health System (Sus), 2012-2016, Perspectives and Challenges for the Brazilian Context

    Oct 1, 2017, 00:00

  • Seal or Varnish? Cost-Effectiveness of Fissure Sealants Versus Fluoride Varnish in Preventing Dental Decay in Children

    Oct 1, 2017, 00:00

  • Force Of Infection Of Helicobacter Pylori In Mexico- Evidence From A National Survey

    Oct 1, 2017, 00:00

  • External Validation of A Mapping Algorithm To Estimate Eq-5d-3l Utilities From Oxford Knee Score Responses

    Oct 1, 2017, 00:00

  • The Need For Developing A Decision Aid Tool About Feeding Options

    Oct 1, 2017, 00:00

  • A Conceptual Model For Pediatric Gastroesophageal Reflux

    Oct 1, 2017, 00:00

  • Secukinumab is Dominant Vs. TNF-Inhibitors in the Treatment of Active Ankylosing Spondylitis- Results from a Turkish Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • A Healthcare Policy Study To Build A Roadmap for Rare Disease Management Under The Egyptian Healthcare System

    Oct 1, 2017, 00:00

  • Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • Clinical And Economic Benefit Of Upper Airway Stimulation For Obstructive Sleep Apnea In The German Setting

    Oct 1, 2017, 00:00

  • Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy

    Oct 1, 2017, 00:00

  • Consistency Assessment of International Drug Price Comparisons

    Oct 1, 2017, 00:00

  • Costo Efectividad Del USO De Ticagrelor Frente A Copidogrel En Pacientes CON Síndrome Coronario Agudo En Colombia

    Oct 1, 2017, 00:00

  • Estimation of the Additional Budget Saving Potential Due to the Rapid Adoption of An Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Spain

    Oct 1, 2017, 00:00

  • Risk of Dipeptidyl-Peptidase-4 (Dpp-4) Inhibitors On Site-Specific Cancer- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Estimating Survival After Radical Prostatectomy In Prostate Cancer; A Propensity-Score Matching Method

    Oct 1, 2017, 00:00

  • The Use of Real World Data for Nice Decision-Making- A Review of Submissions To Three Treatment Effectiveness Evaluation Programmes In 2015 And 2016

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City

    Oct 1, 2017, 00:00

  • Systematic Literature Review of the Impact of Asthma Support Programs Dedicated to Adult Patients

    Oct 1, 2017, 00:00

  • Literature Review of The Cost of Dementia on China

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ulinastatin for Patients Undergoing Hepatectomy- A Discrete Event Simulation Model

    Oct 1, 2017, 00:00

  • Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis

    Oct 1, 2017, 00:00

  • Programa Stewardship- Otimizando A Terapia Antimicrobiana Com Eficiência Em Um Hospital De Ensino De Referência Em Fortaleza, Ceará

    Oct 1, 2017, 00:00

  • Burden of Hospitalizations Related To Spinal Tumors in Fran Evolution Between 2012 and 2014

    Oct 1, 2017, 00:00

  • Pharmacoeconomics Analysis of Sertindole Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Biosimilars And Reference Biotechnologic Drugs- Comparison Of The Biosimilars’ Effect On Reference Drug’s Price For EU, USA And Turkey

    Oct 1, 2017, 00:00

  • Primary Nonadheren Do Differences Exist Between Life Sustaining And Quality Of Life Medications?

    Oct 1, 2017, 00:00

  • To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Relative Value of Evidem Mcda Framework for Reflective Drug Evaluation Among Therapeutic Positioning Report Evaluators From The Spanish Agency of Medicines

    Oct 1, 2017, 00:00

  • An Observational Retrospective Cohort Database Study To Estimate Costs Regarding Immunoglobulin Use for Itp Treatment In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Evaluating Health Impact Of Common Chronic Conditions On Quality Of Life Of EQ-5D-3L In Older Chinese

    Oct 1, 2017, 00:00

  • Antineoplásicos De Maior Impacto Financeiro No Instituto Nacional De Cancer Do Brasil

    Oct 1, 2017, 00:00

  • When The Price Is Right- When, In Practice, Are Confidential Discounts Introduced In The Nice Process?

    Oct 1, 2017, 00:00

  • Assessing Racial Disparity In Palliative Care Consultation And The Impact Of Palliative Care Consultation On Hospi A Multi-Hospital Analysis

    Oct 1, 2017, 00:00

  • Social Burden of Copd

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life, Work Productivity And Activity Impairment Associated With Clostridium Difficile Infection In China, Brazil, Europe and The United States

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a Vs. First-Line Injectable Disease-Modifying Therapies For The Treatment of Relapsing-Remitting Multiple Sclerosis In Spain

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Morocco- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma

    Oct 1, 2017, 00:00

  • Analysis of Drug Utilisation Data Sources to Enable Nationwide Value-Based Pricing of Medicines Across Healthcare Systems in Europe

    Oct 1, 2017, 00:00

  • Bayesian Methodology Considering Historical Data To Predict Overall Survival From Immature Trial Data In Oncology

    Oct 1, 2017, 00:00

  • Potential Funding Sources For Breakthrough Therapies

    Oct 1, 2017, 00:00

  • Copyright/Subscription

    Oct 1, 2017, 00:00

  • Expected Value of Information Analysis to Evaluate the Potential Gains of an RCT Comparing Wound Dressings

    Oct 1, 2017, 00:00

  • Quality of Life for Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (PNF)

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of Fidaxomicin Versus Vancomycin and Metronidazole for the Treatment of Clostridium Difficile

    Oct 1, 2017, 00:00

  • Multivariate Network Meta-Analysis of Survival Function Parameters

    Oct 1, 2017, 00:00

  • Health Economic Analysis Of Pneumococcal Conjugated Vaccines For Mexico, Under A Technical Parity Scenario

    Oct 1, 2017, 00:00

  • Model Attention Improve The Hospital Nutrition Processes Under The Center Of Excellence Concept

    Oct 1, 2017, 00:00

  • Incidence of Non-Small-Cell Lung Cancer And Burden of Egfr Mutations- A 10-Year Global Forecast

    Oct 1, 2017, 00:00

  • Economic Evaluations of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain- A Systematic Review

    Oct 1, 2017, 00:00

  • 90-Day Mortality And Its Predictors In Men With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In The Emergency Frequency At Patients With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (SB4) for the Treatment of Approved Etanercept Indications in the Republic of Ireland

    Oct 1, 2017, 00:00

  • The Role of Stakeholder Engagement in E-Health and the use of Big Data to Predict Health Outcomes

    Oct 1, 2017, 00:00

  • Mechanisms Of Trade Margin Regulation Of Prescription Drugs- Comparison Of 15 Eu Countries

    Oct 1, 2017, 00:00

  • Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela

    Oct 1, 2017, 00:00

  • Rasch Measurement Analysis Of The Lower Extremity Functional Scale For Foot And Ankle Patients

    Oct 1, 2017, 00:00

  • Comparing Quality of Life of (RT-PA) with No-(RT-PA) in Stroke Attacked Patients

    Oct 1, 2017, 00:00

  • A Retrospective Premier Database Study To Compare Repair of Ventral Hernia With Phasixtm VS Stratticetm In The Inpatient Hospital Surgical Setting

    Oct 1, 2017, 00:00

  • Treatment Patterns Among Newly Diagnosed Diabetes Patients in Dubai

    Oct 1, 2017, 00:00

  • Can Early Access Support Continued Access? The Relationship Between Eams And Nice

    Oct 1, 2017, 00:00

  • Special Considerations for Conducting Qualitative Interviews With Cancer Patients and Their Caregivers for The Purpose of Developing Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Embedding Randomized Controlled Trials into Medical Practice

    Oct 1, 2017, 00:00

  • Influência Dos Fatores Socioeconômicos Na Incidência De Câncer De Mama- Revisão Sistemática

    Oct 1, 2017, 00:00

  • Characteristics and cost burden of adverse drug reactions in a tertiary health care hospital in southern chile

    Oct 1, 2017, 00:00

  • Prescription Analysis on Off-Label Drugs In Pediatric Patients Using The Claims Data of The National Health Insurance In Korea

    Oct 1, 2017, 00:00

  • Modelling The Societal Impact Of Alirocumab In Patients With Severe Hypercholesterolemia Treated With Apheresis In Germany

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Using Solifenacin And Modified-Release Tamsulosin Fixed Dose Combination for Treatment of Storage Symptoms Associated With Benign Prostatic Hyperplasia

    Oct 1, 2017, 00:00

  • Orphan Drugs In Fran Key Market Access Incentives

    Oct 1, 2017, 00:00

  • Integrated 2 Screw De-Rotation/Compression, Cepahlo-Medulary Device Reduces Implant Related Complications and Improves Health Related Quality of Life in Patients with Intertrochanteric Fractures, A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Delaying Second Line Diabetes Treatment Onset In Patients Uncontrolled With Metformin Xr In Saudi Arabia- Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Analysis of Oral Hypoglycemic Drugs Consumption in Ukraine in 2015

    Oct 1, 2017, 00:00

  • Adapting The United States’ Antimicrobial Stewardship Programme Guidelines To Build An Economic Evaluation Framework For Chinese Hospitals

    Oct 1, 2017, 00:00

  • Factors Affecting Polypharmacy in Elderly Patients with Diabetes in Greece

    Oct 1, 2017, 00:00

  • Economic Evaluation And Cost-Effectiveness Threshold In Practice Of Decision-Making On Orphan Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Pentaray High Density Mapping Catheter In Treatment Of Ventricular Tachycardia In Turkey

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Daclizumab Beta Vs Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis Patients With Inadequate Response To Prior Treatment In Scotland

    Oct 1, 2017, 00:00

  • Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma

    Oct 1, 2017, 00:00

  • Comparison of Secukinumab Vs Infliximab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison of Opoid Substitution Therapy Vs. Non-Pharmcologic Therapy In The State of Kuwait

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Psoriatic Arthritis (Psa) Patients May Result in Poor Health-Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Transfusion Trends In Primary and Revision Total Joint Arthroplasty- Are Recent Declines Shared Equally?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Point-Of-Care Test For Renal Function Measurement In Community Pharmacies In The Netherlands To Prevent Antibiotic-Related Hospitalizations

    Oct 1, 2017, 00:00

  • Economic Benefits of SFLT-1/PLGF Testing for Preeclampsia in Colombia- A Fiver Year Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Cost-Minimization Analysis Of HPV 16/18 Genotyping Test Versus HPV Reflex Genotyping For Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Antibiotic Stewardship Policy in Biella General Hospital (Italy)- A Five-Year Surveillance

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Cost Impact Analysis of Needlestick Injuries In India

    Oct 1, 2017, 00:00

  • The Impact of Health Policy on The Pharmaceutical Supply Chain In France

    Oct 1, 2017, 00:00

  • Chronic Heart Failure (CHF) In The Czech Republic- Cost-of-Illness Analysis Disease Burden Based on Ahead Registry Data Mining

    Oct 1, 2017, 00:00

  • Considerations for The Selection of Written Chinese Variants In The Process of Translating and Linguistically Validating Clinical Outcome Assessments (COAS)

    Oct 1, 2017, 00:00

  • Prevalence of Cardiovascular Disease In Type 2 Diabetes- A Global Systematic Review

    Oct 1, 2017, 00:00

  • Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC)- Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And Regorafenib

    Oct 1, 2017, 00:00

  • Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

    Oct 1, 2017, 00:00

  • Which Information Sources Should Be Used To Identify Studies for Systematic Reviews of Economic Evaluations In Healthcare?

    Oct 1, 2017, 00:00

  • Psoriasis (PSO) Patients’ Profile And Impact of The Disease on Patients’ Quality of Life and Work Productivity In A Real-Life Setting In Brazil

    Oct 1, 2017, 00:00

  • Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison

    Oct 1, 2017, 00:00

  • Exenatide In Obese Or Overweight Patients Without Diabetes- A Systematic Review And Meta-Analyses Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Determinantes Do Atraso Escolar E DA Obesidade NOS Adolescentes Brasileiros (2012 E 2015)

    Oct 1, 2017, 00:00

  • Reporting Quality Transparency Of Published Network Meta-analysis. Is it Satisfactory?

    Oct 1, 2017, 00:00

  • Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI)- Real World Evidence from 26 US Institutions

    Oct 1, 2017, 00:00

  • Cross-Cultural Adaptation And Validation Of The PEDSQL Cardiac Module Version 3.0

    Oct 1, 2017, 00:00

  • Diabetes Mellitus Self-Management Interventions in Latino Adults in the United States - The Role of Pharmacists

    Oct 1, 2017, 00:00

  • Hepatitis C Virus- Determinants Of Patients’ Management Costs

    Oct 1, 2017, 00:00

  • Addressing Uncertainty In Wound Management Using A Modified Delphi Methodology

    Oct 1, 2017, 00:00

  • Evaluating Physicians’ Perception Of Limitations And Obstacles Against The Effectiveness Of “Audit And Feedback” And “Printed Educational Materials” Interventions On Prescribing Behavior- A Qualitative Study

    Oct 1, 2017, 00:00

  • The Impact of Managed Entry Agreements on Drug Time to Market in Italy

    Oct 1, 2017, 00:00

  • Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan- A Literature Review

    Oct 1, 2017, 00:00

  • Management Of Healthcare Priorities By Single Natural Resource Driven Economies In Emerging Markets During Commodity Price Fluctuations

    Oct 1, 2017, 00:00

  • Cost-Utility Of Liquid Chromatography -Tandem Mass Spectrometry (LC-MS/MS)-Based Urine Analyses To Improve Adherence To Antihypertensive Treatment

    Oct 1, 2017, 00:00

  • An Introductive Analysis of the Timeframe from European Drugs Approval to the Sicilian Hospital Formulary Inclusion

    Oct 1, 2017, 00:00

  • Representing Uncertainty In Economic Evaluations- Getting More From PSA Results

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Biological Therapies In Psoriasis Using Real World Evidence

    Oct 1, 2017, 00:00

  • Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes About Ebola Virus Among Community Residents In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Federal Spending on Infliximab in Brazil- An Analysis of Purchases from 2007-2015

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of High-Throughput, Non-Invasive Prenatal Testing For Fetal Rhesus D Status

    Oct 1, 2017, 00:00

  • Economic Burden of Cardiovascular Disease In Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Efficacy And Safety Outcomes of Recanalization Procedures In Patients with Acute Symptomatic Pulmonary Embolism- Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Reporting Clinical Outcomes In Tavi Registries

    Oct 1, 2017, 00:00

  • Α Systematic Review of Economic Evaluations of Biological Therapies for the Treatment of Ulcerative Colitis

    Oct 1, 2017, 00:00

  • What's the Reality of Real-World Evidence in Health Technology Appraisal?

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs Of Treating Controlled And Uncontrolled Carcinoid Syndrome- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • Functional Assessment After Treatment Of Upper Extremity Soft Tissue Sarcomas Using Structured Outcome Measures- A Systematic Review

    Oct 1, 2017, 00:00

  • Tocilizumab after A First-Line with Anti-Tnf in Rheumatoid Arthritis- A Cost-Consequence Analysis in the Italian Setting

    Oct 1, 2017, 00:00

  • Treatment Switching and Power of ITT and RPSFTM

    Oct 1, 2017, 00:00

  • Real-World Patient Characteristics And Patterns Of Care Among Metastatic Urothelial, Head And Neck, Non-Small Cell Lung Cancer Patients Using A German Sickness Fund Claims Database

    Oct 1, 2017, 00:00

  • Rotavirus Vaccination May Reduce Acute Gastroenteritis Rates Across All Age Groups In England

    Oct 1, 2017, 00:00

  • Utilization Patterns of Lipid-Lowering Therapies in Patients at High Risk for or with Atherosclerotic Cardiovascular Disease- A Population-Based Study in South Korea

    Oct 1, 2017, 00:00

  • Facilitators and Barriers to Adult Vaccination in South East Asia and Latin America

    Oct 1, 2017, 00:00

  • Effectiveness Of Osteoporosis Drugs In Preventing Secondary Hip Fractures In Women On Dialysis

    Oct 1, 2017, 00:00

  • Comorbidities in Multiple Sclerosis- A Descriptive Longitudinal Clustering Analysis of Healthcare Resource Utilization Among MS Patients in IBM Explorys Database

    Oct 1, 2017, 00:00

  • Cost Implications Of Tedizolid Introduction For The Treatment Of Complicated Skin And Soft Tissue Infections In A Russian Multi-Field Hospital

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Effectiveness of The Peripherally Inserted Central Venous Catheter in Adult and Pediatric Patients

    Oct 1, 2017, 00:00

  • European Study on Acute Cough in Children- Results of Poland

    Oct 1, 2017, 00:00

  • Survival Rates In Primary Hepatic Carcinoma Patients With Cirrhosis In South Korea- A Retrospective Analysis of 68,328 Patients In The National Cancer Registry

    Oct 1, 2017, 00:00

  • Current Situation And Development Of Chronic Diseases In China

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Exemestane Versus Capecitabine Monotherapy for Patients with Hormone Receptor–Positive and Her2-Negative, Metastatic Breast Cancer from National Cancer Institute Prespective in Egypt

    Oct 1, 2017, 00:00

  • National Adoption of New Immunossupresants for Solid Organs and Stem Cells Transplantations

    Oct 1, 2017, 00:00

  • Comparison Of Previous IPHA-HSE Agreement Effects On The Hta Assessment Process In Ireland (2009 – 2016)

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Ziprasidone Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Analysis of The Individual Economic Burden (BORNE-COST BY THE PATIENTS) In Adult Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole in The Prophylaxis of Invasive Fungal Infections in Acute Leukemia Patients in Colombia

    Oct 1, 2017, 00:00

  • Allowing Methadone’s Prescription To General Practitioners- A Positive Impact on The French Healthcare Insurance Expenditures

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Radiofrequency Catheter Ablation Of Atrial Fibrillation Based On Real-World Data- Manual Or Robotic?”

    Oct 1, 2017, 00:00

  • Early Economic Evaluation of The New Atypical Antipsychotic

    Oct 1, 2017, 00:00

  • Direct Costs of Long-Term Psychiatric Hospitalization in Public Hospital of the State of Sao Paulo, Brazil- The Complexo Hospitalar Juquery Case

    Oct 1, 2017, 00:00

  • A Sistematic Review Of The Cost-Effectiveness Of Vaccinating Elderly With The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23)

    Oct 1, 2017, 00:00

  • Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • A Trend Towards Increased Use Of Patient Access Schemes (PAS) To Gain UK Reimbursement

    Oct 1, 2017, 00:00

  • Mapping Acroqol Scores to EQ-5D to Obtain Utility Values for Patients with Acromegaly

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Prescription Patterns and their Impact on Outcome of Blood Pressure in Ethiopia-A Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • Use of Thalidomide In Erythematosus Lupus Treatment

    Oct 1, 2017, 00:00

  • Avoiding A Market For Lemons With Pharmaceuticals- How Risk-Sharing Mechanisms Can Improve Allocation

    Oct 1, 2017, 00:00

  • Exploring The Efficacy And Safety of Radiofrequency Ablation In Patients With Spinal Metastases- A Systematic Review

    Oct 1, 2017, 00:00

  • Value Of A Pilot Study In A Retrospective Chart Review- Final Protocol Design Should Base On Pilot Results

    Oct 1, 2017, 00:00

  • The Practical Application of a Digital Therapeutic Education Platform for Cardiovascular Rehabilitation

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Oxycodone In Patients Who Do Not Respond To Morphine From The Brazilian Public Health System Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence

    Oct 1, 2017, 00:00

  • New European Medical Device Directive (MDD) Comes Into Effect In 2020- Chances And Consequences For Stakeholders

    Oct 1, 2017, 00:00

  • Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cerebral Oximetry Monitoring In Carotid Endarterectomy- The Emocar Randomized Controlled Trial (May 2011 - April 2016)

    Oct 1, 2017, 00:00

  • Horizon Scanning In Oncology – Rapid Scanning Approach In Slovakia

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of A Physician-Implemented, Medication Screening Tool in Older Hospitalised Patients in Ireland

    Oct 1, 2017, 00:00

  • Variation In Health Technology Assessment And Reimbursement Decisions In England, France, And Germany- Spotlight On The Impact Of Uncertainty

    Oct 1, 2017, 00:00

  • IMPACT OF WEIGHT LOSS (WL) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG LATIN AMERICAN (LA) SUBJECTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN PHASE 3 STUDIES OF CANAGLIFLOZIN (CANA)

    Oct 1, 2017, 00:00

  • Comparison Of Costs And Care Of Lung Cancer Patient At The End-Of-Life In Germany Depending On The Time Of Survival After Diagnosis

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico

    Oct 1, 2017, 00:00

  • Current and Potential Future Changes In The Methodology of Emerging Value Frameworks

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda

    Oct 1, 2017, 00:00

  • Direct Costs of Health Care of Cystic Fibrosis, The Case of A Health Insurer In Colombia

    Oct 1, 2017, 00:00

  • A Predictive Tool For Characterizing And Visualizing Populations Under Counterfactual Treatment Assignment

    Oct 1, 2017, 00:00

  • Treatment Of Patients With Rheumatoid Arthritis- Real World Population-Based Evidence From France

    Oct 1, 2017, 00:00

  • The Traditional Ethnobotanical Knowledge Applied in Parasitology in the Andean Cordillera of Ecuador

    Oct 1, 2017, 00:00

  • Regional Policies Impact on Biosimilar Adoption For Autoimmune Diseases In Italy

    Oct 1, 2017, 00:00

  • Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy

    Oct 1, 2017, 00:00

  • Applying Nice End Of Life Criteria In The ERA Of Drug Approvals Based On Single-ARM Trial Data

    Oct 1, 2017, 00:00

  • Market Dynamics of Statin Medications

    Oct 1, 2017, 00:00

  • Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2- A French Nationwide Cohort Of 100,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis- 24-Week Results of The Phase Iii Go Vibrant Trial

    Oct 1, 2017, 00:00

  • Assessment of Economic Model Stability By Repeated One-Way Sensitivity Analysis

    Oct 1, 2017, 00:00

  • Alemtuzumab Is The Most Cost-Effective Option In Comparison To Available Therapies In The Treatment of Rrms From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer- A Cost-Effectiveness Analysis from A UK Healthcare Perspective

    Oct 1, 2017, 00:00

  • Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease- Based On Korean National Insurnance Claims Data

    Oct 1, 2017, 00:00

  • Treatment interruption of Biological Drugs in Rheumatoid Arthritis- An Assessment of Case-Reports

    Oct 1, 2017, 00:00

  • Is Willingness to Pay Higher for Cancer Prevention and Treatment?

    Oct 1, 2017, 00:00

  • Hospital Burden 18 Months after Surgical Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • Economic Impact of Alirocumab In The Management of Primary Hypercholesterolemia or Mixed Dyslipidemia- An Italian Perspective

    Oct 1, 2017, 00:00

  • Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Obinutuzumab Plus Chlorambucil in Patients with Previously Untreated Chronic Lymphocytic Leukemia and Coexisting Conditions

    Oct 1, 2017, 00:00

  • Do Countries With Similar GDPS And Health Expenditures Reimburse The Same Cancer Drugs?

    Oct 1, 2017, 00:00

  • Challenges in Optimising Real World Evidence for Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Knowledge And Confidence Of Healthcare Providers Working At Hospitals About Appropriate Prescribing For Geriatrics

    Oct 1, 2017, 00:00

  • Assessment of Antidiabetic Drugs In Fran What Is The Basis For A Reimbursement Recommendation?

    Oct 1, 2017, 00:00

  • Analysis of Consumption of Anti-TB Medicines in Ukraine During 2012-2016

    Oct 1, 2017, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease In The Spanish Region of Extremadura

    Oct 1, 2017, 00:00

  • Treatment Satisfaction Among Patients with Moderate-to-Severe Plaque Psoriasis in Brazil

    Oct 1, 2017, 00:00

  • Health Technology Assessment Decisions in Immuno-Oncology Therapies- Results, Rationales, and Trends

    Oct 1, 2017, 00:00

  • Analysing Uptake Of New Medicine Service In English Community Pharmacies

    Oct 1, 2017, 00:00

  • Health Economics And Outcomes Research Needs Assessment For Latin America- Relationship Between Perceived And Expected Quality Of Knowledge In A Self-Assessment Survey

    Oct 1, 2017, 00:00

  • Caracterización Del Riesgo Cardiovascular Por Factores Asociados- Análisis De Base De Datos De UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Minimizing Bias In Indirect Comparisons Utilizing Virtual Patient Level Data

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Enzalutamide and Abiraterone for Treatment of Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2017, 00:00

  • A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of ...

    Oct 1, 2017, 00:00

  • The Effect Of Chronic Diseases, Financial Hardship And Personality Types In Patient's Medication Adherence

    Oct 1, 2017, 00:00

  • Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • HTA MCDA In The Treatment of Macular Edema

    Oct 1, 2017, 00:00

  • Economic Evaluation For Establishing Stroke Unit Followed By Early Supported Discharge In Egypt

    Oct 1, 2017, 00:00

  • Judicialização Da Saúde No Brasil- Proximidade Dos Magistrados Com As Políticas Públicas De Saúde

    Oct 1, 2017, 00:00

  • The Burden of Spondyloarthritis – Paasport A Population-Based Study

    Oct 1, 2017, 00:00

  • Modelling the Societal Impact of Secukinumab in Patients with Psoriatic Arthritis in Germany

    Oct 1, 2017, 00:00

  • Cost-Utility Of Novel Tests After A Negative Prostate Biopsy

    Oct 1, 2017, 00:00

  • Cost of Ilness Analysis- A Comparison of The Costs of Drug Therapy for Patients with Prostate Cancer, Breast Cancer, Colon Cancer, Melanoma and Renal Cell Carcinoma in Moscow

    Oct 1, 2017, 00:00

  • Review of Surrogate Endpoint Validation Methodologies and Application In Solid Tumour Htas

    Oct 1, 2017, 00:00

  • Drug Utilisation Study of Anti-Obesity Products Dispensed by Pharmacies in South Africa

    Oct 1, 2017, 00:00

  • Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Predictors Of Activity And Participation In People With Motor Neurone Disease, Multiple Sclerosis And Parkinson’s Disease

    Oct 1, 2017, 00:00

  • Substantiation of the National Policy of Pricing and Availability of Drugs

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Brazil

    Oct 1, 2017, 00:00

  • Utilization of Lipid-Lowering Drugs in Slovakia- Comparison of Data from Different Sources

    Oct 1, 2017, 00:00

  • A Fresh Look At The Predictors Of The Number Of HIV Cases In Turkey

    Oct 1, 2017, 00:00

  • Minimally Important Differen Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

    Oct 1, 2017, 00:00

  • Relevance of Surgical Interventions for Treatment of Obstructive Sleep Apnea in Germany

    Oct 1, 2017, 00:00

  • Demand And Supply Side Regulation Of Biosimilar Markets In Germany, France And England And Its Implications For Market Access Of Biosimilars

    Oct 1, 2017, 00:00

  • A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

    Oct 1, 2017, 00:00

  • Vaccines for Herpes Zoster- A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age

    Oct 1, 2017, 00:00

  • Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

    Oct 1, 2017, 00:00

  • Health-Economics Evaluations in France, England, Canada and Autralia- Comparison of Methodologies and Impact on Drugs’ Access To Patients

    Oct 1, 2017, 00:00

  • A Predictive Model To Include Uncertainty In Mean Health Utilities Estimation- Impact Of Social Class, Body Mass Index And Chronic Diseases

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulant (DOAC) Adoption in Practi Utilization, Expenditures, Switching and Adherence

    Oct 1, 2017, 00:00

  • Clinical Pharmacy Services And Workforce Requirements At Ministry Of Health Hospitals During Ten Years Mass Gathering Hajj (2006-2015) In Makah And Al-Medina Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • Association Between Socioeconomic Deprivation And Cancer Incidence And Outcomes Among English CCGS

    Oct 1, 2017, 00:00

  • Effect Of Pharmaceutical Care Intervention On Well-Being Index Of Type 2 Diabetes Outpatients In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Development Of A Tool To Quantify An Individual’s History Of Sun Exposure- Qualitative Phase Of The Development Of The Sun Exposure Questionnaire

    Oct 1, 2017, 00:00

  • Hospitalisations Among A Cohort Of Patients With Heart Failure Versus An Age- And Sex-Matched Cohort Without Heart Failure In England- A Comparative Study Using Cprd Data

    Oct 1, 2017, 00:00

  • Do Characteristics of Patients Influencing the Choice of Pain Treatment by GPS Differ in Osteoarthritis and Cancer? – An Italian Real World Evidence Study

    Oct 1, 2017, 00:00

  • Emerging Markets Tiered Pricing- A Quantitative Assessment Of Local Affordability And Existing Price To Patient

    Oct 1, 2017, 00:00

  • Value Of Treating All Liver Fibrosis Stages To Reach Elimination Of Diagnosed Chronic Hepatitis C- A Modelling Approach In France

    Oct 1, 2017, 00:00

  • Secondary Prevention Cardiovascular Patients In Ireland - Population Characteristics For Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Initiative To Obtain Advanced Therapeutic Outcomes In Multiple Myeloma (Importa Project)

    Oct 1, 2017, 00:00

  • Adesão A Terapia Antihipertensiva E Qualidade De Vida

    Oct 1, 2017, 00:00

  • Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario De 2 Métodos De Screening De Cáncer De Cuello Uterino Basados En Test De Hpv En Argentina

    Oct 1, 2017, 00:00

  • Using Network Meta-Analysis Of Individual Patient Data (IPD) Summary Aggregate Data (SAD) To Identify Which Combinations Of Interventions Work Best For Which Individuals

    Oct 1, 2017, 00:00

  • A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian Cancer

    Oct 1, 2017, 00:00

  • Review of Rare Disease Registries Across EU5 Countries

    Oct 1, 2017, 00:00

  • Estimated Clinical Impact Of Two Oncologic Drug Shortages

    Oct 1, 2017, 00:00

  • Comparison of The Long-Term Cost-Effectiveness of Ideglira Versus Multiple Daily Insulin Injections In The Spanish Setting Using Real-World Clinical Data

    Oct 1, 2017, 00:00

  • Human Papilloma Virus In Italy- Cost Of Illness And Potential Savings Due To HPV9 Primary Prevention

    Oct 1, 2017, 00:00

  • Non Adherence to Inhalational Medications and Associated Factors Among Patients with Asthma in A Referral Hospital in Ethiopia, Using Validated Tool Tai

    Oct 1, 2017, 00:00

  • Comparison of Utility Values Implemented in Disease Models of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • European Real World Data Sources To Characterise Flares In Patients With Systemic Lupus Erythematosus- A Review

    Oct 1, 2017, 00:00

  • Burden Of Disease, Healthcare Pathways And Costs Of Primary Progressive Multiple Sclerosis- An Italian Real World Study On 10 Million Inhabitants

    Oct 1, 2017, 00:00

  • Real World Evidence In Europe - The Results Of An Expert Survey

    Oct 1, 2017, 00:00

  • Oncologic Pain Attitudes, Intensity And Treatment In Brazil

    Oct 1, 2017, 00:00

  • Impacto Económico En Las Patologías De Salud Mental, Neurológicas Y Demencias En Colombia

    Oct 1, 2017, 00:00

  • Antimalarial Treatment Outcomes In Ethiopia- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Efetividade Na Solicitação De Exames Laboratoriais Na Atenção Básica

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Supraciliary Micro-Stent Glaucoma Implant Combined With Cataract Surgery In Management Of Primary Open-Angle Glaucoma (POAG) From The Canadian Payer Perspective

    Oct 1, 2017, 00:00

  • Estimation Of Health-Related Quality Of Life (HRQOL) In Cancer Patients Utilising A Time-To-Death Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Molecular Versus Conventional Screening For Acute Intestinal Infectious Diseases- Novel Application Of Agent-Based Modelling

    Oct 1, 2017, 00:00

  • Lower Hemoglobin (HB) Levels Negatively Impact Quality Of Life (QOL) Among Peritoneal Dialysis (PD) Patients- Results From A National Representative Cohort Study In Brazil (BRAZPD)

    Oct 1, 2017, 00:00

  • Are We Prep-Ared For Differences Between Nice And SMC Decision Making?

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Burden of Cytomegalovirus Disease In Immunosuppressed Patients After Haematopoietic Cell Transplantation In England

    Oct 1, 2017, 00:00

  • The Epidemiology and Burden of Paediatric Multiple Sclerosis- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Reliability Testing Of The Finnish Version Of The Non-Technical Skills Scale For Trauma (T-Notechs)

    Oct 1, 2017, 00:00

  • Burden Of Ulcerative Colitis In Japan

    Oct 1, 2017, 00:00

  • A Review of The Quality of Life and Educational Burden of Allergic Rhinitis on Adolescents

    Oct 1, 2017, 00:00

  • Incidence of Psychiatric Disorders in Women WITH a Suspected But Unconfirmed Diagnosis of Breast or Genital Organ Cancer

    Oct 1, 2017, 00:00

  • Varying Nature Of The Assessment Of Advanced Medicinal Products (Atmp) In Germany

    Oct 1, 2017, 00:00

  • A Multi-Dimensional Assessment of the Conservative Technologies Used for the Treatment of Uterine Fibroids in Italy

    Oct 1, 2017, 00:00

  • Healthcare Resource Use And Economic Burden Attributable To Respiratory Syncytial Virus In The United States

    Oct 1, 2017, 00:00

  • Resource Utilisation And Costs Associated With Intravenous Patient-Controlled Analgesia Morphine For Post-Operative Pain Management In A Teaching Hospital Setting In Ireland

    Oct 1, 2017, 00:00

  • Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Evaluación De Efectividad Y Seguridad De La Terapia Farmacológica Para EL Tratamiento De La Enfermedad De Parkinson Inicial Y Avanzada En Colombia

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Analyzing the Treatment Cost of Liver Cirrhosis from Healthcare Payer’s Perspective of Vietnam in 2015

    Oct 1, 2017, 00:00

  • Surveillance Status, Diagnostic Accuracy And Survival Of The National Liver Cancer Surveillance Program

    Oct 1, 2017, 00:00

  • Systematic Review Of Statins Effectiveness In Prevention Secondary In Elderly

    Oct 1, 2017, 00:00

  • Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy

    Oct 1, 2017, 00:00

  • Comparison Of Post-Creation Procedures And Related Costs Between Traditional Surgical Versus A New Endovascular Approach To Creating An Arteriovenous Fistula- A Usrds Comparison

    Oct 1, 2017, 00:00

  • Differences In Vaccine Pricing Between High-Income And Low-Income Markets

    Oct 1, 2017, 00:00

  • Patient Prefences in Colorectal Adenoma Surveillance

    Oct 1, 2017, 00:00

  • Long Term Efficacy of Pertuzumab For HER2+ Metastasic Breast Cancer Ecuadorian Population

    Oct 1, 2017, 00:00

  • A Societal Utility Study to Elicit Values for Adverse Events and Surgical Complications in Moderate to Severe Crohn’s Disease in UK

    Oct 1, 2017, 00:00

  • Patient-Preferred Design Features Of Tnf Inhibitor Self-Injection Devices- Insights From A Rheumatoid Arthritis Auto-Injector Preference Study

    Oct 1, 2017, 00:00

  • Knowledge Of Leptospirosis Among Malaysian Wet Market Sellers

    Oct 1, 2017, 00:00

  • Mixed Methods Evaluation of An Itch Numeric Rating Scale Among Adult and Adolescent Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Household Storage Of Medicines And Associated Factors In Tigray Region, Northern Ethiopia

    Oct 1, 2017, 00:00

  • Situation of Rheumatoid Arthritis Patients Treated with Biologics In Germany Based on a Claims Data Analysis

    Oct 1, 2017, 00:00

  • Mapping The Systematic Review Toolbox

    Oct 1, 2017, 00:00

  • Willingness To Pay For Qaly In The Czech Republic Between 2013 And 2017- A Review

    Oct 1, 2017, 00:00

  • Precision Cost-Effectiveness Analysis Of Radiofrequency Catheter Ablation In A Real-World Atrial Fibrillation Population

    Oct 1, 2017, 00:00

  • Expenditure On Non-Pharmaceutical Products In Ireland During A Period Of Healthcare Cost Containment

    Oct 1, 2017, 00:00

  • tackling Network Meta-Analysis Methodological Challenges- A Case Study On Biologic Treatments For Moderate To Severe Plaque Psoriasis In Children And Young People

    Oct 1, 2017, 00:00

  • Costo De La Diabetes Mellitus En El Sistema De Salud Colombiano

    Oct 1, 2017, 00:00

  • Analysis of Metastatic Breast Cancer Policies to Advance Access To Treatment in Latin America- Research Methodology and Approaches used to Survey the Current Policy Environment

    Oct 1, 2017, 00:00

  • South West Icers – The Experience of Nice’s Diagnostics Assessment Programme

    Oct 1, 2017, 00:00

  • Outcomes in Contact Force Technology Use For Cardiac Ablation – Role of Procedure Volume

    Oct 1, 2017, 00:00

  • Breakfast Consumption And Associated Factors Among Students In Olabisi Onabanjo University, Ogun State, Nigeria

    Oct 1, 2017, 00:00

  • An Observational Cross-Sectional Database Study To Estimate Hospitalization Costs Related To Cardiovascular Disease In Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • Developing A Methodology For Using Acoustic Simulations Of Hearing Loss To Describe Health States

    Oct 1, 2017, 00:00

  • Indirect Costs and Caregiver Burden of Schizophrenia In European Countries – Results of A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Factores Asociados A La Automedicación En Usuarios De Boticas Y Farmacias En Perú- Análisis De La Encuesta De Satisfacción De Los Servicios De Salud (ENSUSALUD) 2015

    Oct 1, 2017, 00:00

  • The Impact Of The Study Design Submitted For The Early Benefit Assessment On The Pricing For Oncologic Drugs

    Oct 1, 2017, 00:00

  • A Real World Evidence Model To Compare Direct Oral Anticoagulants Safety Outcomes For Atrial Fibrillation Patients In Spain

    Oct 1, 2017, 00:00

  • Price Life Cycle Management Of Orphan Drugs In France

    Oct 1, 2017, 00:00

  • Development Of A Mortality Risk Prediction Tool For Patients With Heart Failure Or Chronic Kidney Disease At Risk Of Hyperkalaemia

    Oct 1, 2017, 00:00

  • Will It Blend? Incorporation Of IRP Within HTA Systems

    Oct 1, 2017, 00:00

  • Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

    Oct 1, 2017, 00:00

  • Cost Analysis of Several Treatment Sequences Used for The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal- The Case for Cladribine Tablets

    Oct 1, 2017, 00:00

  • POCT Cost Effectiveness Case Study On The Way To A Hb-Hta Unit

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Systematic Evaluation of Bevacizumab Treatment for Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • The Burden Of Albinism- Creation Of A Questionnaire

    Oct 1, 2017, 00:00

  • Estudio De Costo- Consecuencia De Darbepoetina Alfa Para EL Tratamiento De Anemia Sintomática Derivada De La Enfermedad Renal Crónica En Colombia

    Oct 1, 2017, 00:00

  • Cancer Drugs In Algeria And Six Other Countries- A Cross-Country Price Comparison Study

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74 (current)
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »